Scholar Rock Sees Phase III Path For SMA Drug

Apitegromab Being Studied As Monotherapy And In Combination

 
• By Alaric DeArment
3D spinal cord
Scholar Rock announced 12-month results from its Phase II TOPAZ study of apitegromab • Source: Shutterstock

More from R&D

More from Scrip